论文部分内容阅读
目的:探讨在重症肺炎病情评估中,监测动脉血乳酸水平后,产生临床意义。方法:选取2015年3月到2016年3月期间,在我院治疗的72例重症肺炎患者进行研究。将其分为乳酸降低组、乳酸升高组。对比两组患者治疗前后的动脉血乳酸水平与APACHEⅡ评分。结果:治疗后,乳酸降低组的动脉血乳酸水平为(3.3±1.7mmol/L)。乳酸升高组的动脉血乳酸水平为(15.4±6.1mmol/L)。两组相比,差异显著,P<0.05,具有统计学意义。结论:在重症肺炎患者治疗中,加强动脉血乳酸水平的监测,有助于了解患者的病情程度,然后及时采取有效的治疗措施,对早期治疗来说非常重要。因此,值得在临床上大力推广。
Objective: To explore the clinical significance of the monitoring of arterial blood lactic acid in the assessment of severe pneumonia. Methods: From March 2015 to March 2016, 72 patients with severe pneumonia treated in our hospital were selected. Divided into lactic acid reduced group, lactic acid increased group. The arterial blood lactate levels and APACHE II scores before and after treatment were compared between the two groups. Results: After treatment, lactic acid decreased arterial blood lactate levels (3.3 ± 1.7mmol / L). Arterial lactate levels in the group with elevated lactate were (15.4 ± 6.1 mmol / L). The difference between the two groups was significant, P <0.05, with statistical significance. Conclusion: In the treatment of patients with severe pneumonia, the monitoring of arterial blood lactate level will help to understand the patient’s condition, and then take timely and effective treatment measures, which are very important for early treatment. Therefore, it is worth to vigorously promote in clinic.